Mesoblast (MEOBF) FCF Margin (QoQ) (2016 - 2023)
Powered by 
Analysis
Mesoblast (MEOBF) FCF Margin (QoQ) (2016 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 994,127.00 |
| Mar 31, 2023 | -477,991.00 |
| Dec 31, 2022 | -17,953.00 |
| Sep 30, 2022 | 164,147.00 |
| Jun 30, 2022 | 8,081.00 |
| Mar 31, 2022 | -25,646.00 |
| Dec 31, 2021 | -102,161.00 |
| Sep 30, 2021 | 147,217.00 |
| Jun 30, 2021 | 31,206.00 |
| Mar 31, 2021 | 8,671.00 |
| Dec 31, 2020 | 79,382.00 |
| Mar 31, 2020 | 35,087.00 |
| Dec 31, 2019 | -37,655.00 |
| Mar 31, 2019 | -159,182.00 |
| Dec 31, 2018 | 6,329.00 |
| Sep 30, 2018 | 101,958.00 |
| Jun 30, 2018 | 64,453.00 |
| Mar 31, 2018 | -172,110.00 |
| Dec 31, 2017 | 162,294.00 |
| Sep 30, 2017 | 240,656.00 |